Skip to main content
See every side of every news story
Published loading...Updated

Ozempic Weight Loss Ads; New Dietary Guidelines; More Type 1.5 Diabetes Diagnoses

Eli Lilly’s oral drug forglipron showed up to 11% weight loss in trials as clinicians report 83% increase in type 1.5 diabetes diagnoses over the past decade.

Summary by MedPage Today
(MedPage Today) -- Due to sponsored search results -- a form of online advertising -- the Ozempic formulation of semaglutide appears in Google searches for weight loss, despite not being FDA-approved for this indication. (NPR) New analyses...

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

MedPage Today broke the news in New York, United States on Tuesday, November 11, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal